India has reported as many as 422 Omicron cases across 17 states and union territories in India so far and 130 of these people have recovered or migrated, Union health ministry said on December 26.
Maharashtra has recorded the highest number of Omicron cases at 108, followed by Delhi at 79, Gujarat 43, Telangana 41, Kerala 38, Tamil Nadu 34 and Karnataka 31.With 6,987 more people testing positive for COVID-19 in a day, India's total caseload increased to 3,47,86,802, according to the data updated at 8 am.
The death toll has climbed to 4,79,682 with 162 new fatalities, the data stated.
The daily rise in coronavirus infections has remained below 15,000 for the last 59 days now.
The number of active COVID-19 cases declined to 76,766, comprising 0.22 per cent of the total infections, the lowest since March 2020, the ministry said. A decrease of 266 cases has been recorded in the active caseload in a span of 24 hours.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The national COVID-19 recovery rate stands at 98.40 percent, the highest since March 2020, the ministry said. The daily positivity rate was recorded at 0.74 percent. It has remained below 2 percent for the last 83 days.
The weekly positivity rate was recorded at 0.62 percent. It has remained below 1 per cent for the last 42 days, according to the health ministry.
The number of people who have recuperated from the viral disease surged to 3,42,30,354, while the case fatality rate was recorded at 1.38 per cent.
The cumulative doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 141.37 crore.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
India crossed the grim milestone of two crore on May 4 and three crore on June 23.(With PTI inputs)